Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Operating Expenses (2017 - 2022)

Historic Operating Expenses for Iterum Therapeutics (ITRM) over the last 6 years, with Q4 2022 value amounting to $7.9 million.

  • Iterum Therapeutics' Operating Expenses rose 1606.38% to $7.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $30.4 million, marking a year-over-year increase of 2382.52%. This contributed to the annual value of $18.7 million for FY2024, which is 6061.35% down from last year.
  • As of Q4 2022, Iterum Therapeutics' Operating Expenses stood at $7.9 million, which was up 1606.38% from $7.0 million recorded in Q3 2022.
  • Over the past 5 years, Iterum Therapeutics' Operating Expenses peaked at $31.0 million during Q3 2019, and registered a low of $4.6 million during Q4 2020.
  • For the 5-year period, Iterum Therapeutics' Operating Expenses averaged around $13.3 million, with its median value being $8.2 million (2020).
  • Per our database at Business Quant, Iterum Therapeutics' Operating Expenses skyrocketed by 19852.16% in 2018 and then plummeted by 7996.38% in 2020.
  • Over the past 5 years, Iterum Therapeutics' Operating Expenses (Quarter) stood at $24.2 million in 2018, then dropped by 4.16% to $23.2 million in 2019, then tumbled by 79.96% to $4.6 million in 2020, then soared by 47.05% to $6.8 million in 2021, then increased by 16.06% to $7.9 million in 2022.
  • Its last three reported values are $7.9 million in Q4 2022, $7.0 million for Q3 2022, and $8.0 million during Q2 2022.